Furthermore, the accumulation of AD‐like mitogen‐activated protein kinase (MAPT)/Tau disrupts autophagosome‐lysosome fusion by perturbing the ANP32A‐INHAT‐IST1‐ESCRT‐III pathway (Figure 5). This evidence concerns the gene MAPT and Alzheimer disease.